Transporter-Mediated Drug Delivery
Molecules · 24.01.2023 · 28 (3) · 1151
DOI: 10.3390/molecules28031151 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 24.01.2023. Verfasst von Gergely Gyimesi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Membrane Transport Discovery Lab, Department of Nephrology and Hypertension, and Department for BioMedical Research, Inselspital, University of Bern,…. Hauptthemen laut MEDLINE: Membrane Transport Proteins, Prodrugs. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 532 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, Novartis Foundation.
Abstract (Originalsprache)
Transmembrane transport of small organic and inorganic molecules is one of the cornerstones of cellular metabolism. Among transmembrane transporters, solute carrier (SLC) proteins form the largest, albeit very diverse, superfamily with over 400 members. It was recognized early on that xenobiotics can directly interact with SLCs and that this interaction can fundamentally determine their efficacy, including bioavailability and intertissue distribution. Apart from the well-established prodrug strategy, the chemical ligation of transporter substrates to nanoparticles of various chemical compositions has recently been used as a means to enhance their targeting and absorption. In this review, we summarize efforts in drug design exploiting interactions with specific SLC transporters to optimize their therapeutic effects. Furthermore, we describe current and future challenges as well as new directions for the advanced development of therapeutics that target SLC transporters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Membrane Transport Discovery Lab, Department of Nephrology and Hypertension, and Department for BioMedical Research, Inselspital, University of Bern, Freiburgstrasse 15, CH-3010 Bern, Switzerland.
ORCID-Profile: Gergely Gyimesi
Förderung
- Swiss National Science Foundation
- Novartis Foundation
Zitieren
APA
Gyimesi, G., & Hediger, M. A. (2023). Transporter-Mediated Drug Delivery. Molecules, 28(3), 1151. https://doi.org/10.3390/molecules28031151
Vancouver
Gyimesi G, Hediger MA. Transporter-Mediated Drug Delivery. Molecules. 2023;28(3):1151. doi:10.3390/molecules28031151
BibTeX
@article{Gyimesi2023,
author = {Gyimesi, Gergely and Hediger, Matthias A},
title = {Transporter-Mediated Drug Delivery},
journal = {Molecules},
year = {2023},
volume = {28},
number = {3},
pages = {1151},
doi = {10.3390/molecules28031151}
}
EUVIMED